Breaking News on Biopharmaceutical Development & Manufacturing

Image: iStock/kropic

BIO 2016 - San Francisco

San Francisco played host to the biotech world, and we were there to bring all the news and views across the industry to you, our readers

BIO 2016

Commissioner Califf commits to tackling staffing issues at US FDA

23-Jun-2016 - Automated systems and reducing hiring time will be crucial in revamping the US FDA’s “antiquated” HR systems, says Commissioner Robert Califf.

Regulatory INN security? Sandoz disputes proposed biosimilar naming guidance

22-Jun-2016 - The non-proprietary naming debate is “almost a little comical” says Sandoz, which argues a proposed four-letter suffix adds little to aid post-marketing surveillance of biological products.


Quality key for burgeoning US biosimilars market, says BIO panel

17-Jun-2016 - Manufacturing complexity will keep both the number of biosimilar players and pricing discounts low, said an expert panel at BIO last week.

BIO 2016

Technology, not capacity, driving Catalent’s biologics strategy

14-Jun-2016 - Differentiated technologies buoyed by the recent $600m conjugation deal with Roche is driving Catalent’s biologics business, the firm told Biopharma-Reporter at BIO.

BIO 2016

Califf: New FDA guidance to ensure all drug info is available to patients

13-Jun-2016 - Expect industry guidance on product communication soon says US FDA Commissioner Robert Califf, though a more pragmatic approach to social media will be taken.

Dispatches from BIO

GE and PnuVax ink vaccine deal and say single-use will change the industry

10-Jun-2016 - Single-use technology is driving a new era in vaccine development says PnuVax which has acquired IP from GE Healthcare to produce an inactivated yellow fever vaccine.

Dispatches from BIO 2016

Brammer Bio opens new cell and gene therapy manufacturing facility

08-Jun-2016 - The new 50,000 square foot facility in Lexington, MA will be dedicated to late phase development and commercial manufacturing for advanced cell and gene therapies.

Dispatches from BIO

Dedicated or condominium? Patheon talks 'creative' capacity models at BIO

08-Jun-2016 - With problems in forecasting capacity demand, biopharma is looking to a number of new models from third-party manufacturers according to Patheon.

CORRECTION - Dispatches from BIO 2016

Merck & Co. and Fujifilm team to share capabilities at new $60m microbial plant

07-Jun-2016 - A new $60m facility at a MSD site in Ireland will offer Fujifilm Diosynth customers 20,000L of microbial biologics capacity in a collaboration between the two firms.

Live from 2016 BIO International Convention

07-Jun-2016 -   [View the story "Live from 2016 BIO International Convention " on Storify]

Key Industry Events


Access all events listing

Our events, Shows & Conferences...